Results 1 to 10 of about 101,157 (242)

Incidence of Tuberculosis in HIV-Infected Patients Before and After Starting Combined Antiretroviral Therapy in 8 Sub-Saharan African HIV Programs. [PDF]

open access: yes, 2011
SETTIN
Badri   +28 more
core   +2 more sources

Immunohematological Outcome Among Adult HIV Patients Taking Highly Active Antiretroviral Therapy for at Least Six Months in Yabelo Hospital, Borana, Ethiopia

open access: yesJournal of Blood Medicine, 2023
Girma Ashenafi,1 Melatwork Tibebu,2 Dagnamyelew Tilahun,1 Aster Tsegaye2 1Department of Medical Laboratory Sciences, Bule Hora University, Bule Hora, Oromia, Ethiopia; 2Department of Medical Laboratory Sciences, Addis Ababa University, Addis Ababa ...
Ashenafi G   +3 more
doaj  

Comparison of the effectiveness of initial combined antiretroviral therapy with nelfinavir or efavirenz at a university-based outpatient service in Brazil

open access: yesBrazilian Journal of Medical and Biological Research, 2007
Since there are some concerns about the effectiveness of highly active antiretroviral therapy in developing countries, we compared the initial combination antiretroviral therapy with zidovudine and lamivudine plus either nelfinavir or efavirenz at a ...
T. Vanni   +12 more
doaj   +1 more source

HIV-1 Evolutionary Patterns Associated with Metastatic Kaposi's Sarcoma during AIDS. [PDF]

open access: yes, 2016
Kaposi's sarcoma (KS) in HIV-infected individuals can have a wide range of clinical outcomes, from indolent skin tumors to a life-threatening visceral cancer. KS tumors contain endothelial-related cells and inflammatory cells that may be HIV-infected. In
Barbier, Andrew E   +6 more
core   +4 more sources

Maintaining infants and children on highly active antiretroviral therapy

open access: yesSouth African Family Practice, 2006
No abstract available.
Helena Rabie   +2 more
doaj   +1 more source

Nevirapine- and efavirenz-associated hepatotoxicity under programmatic conditions in Kenya and Mozambique. [PDF]

open access: yes, 2012
To describe the frequency, risk factors, and clinical signs and symptoms associated with hepatotoxicity (HT) in patients on nevirapine- or efavirenz-based antiretroviral therapy (ART), we conducted a retrospective cohort analysis of patients attending ...
Biot, M   +6 more
core   +2 more sources

Dyslipidemia in AIDS patients on highly active antiretroviral therapy

open access: yesBrazilian Journal of Infectious Diseases, 2011
Highly active antiretroviral therapy (HAART) reduces AIDS-related morbidity and mortality, however it has been associated with metabolic abnormalities. This study estimated the prevalence of lipid abnormalities and related factors among patients on HAART.
Max Weyler Nery, MD, MSc   +2 more
doaj   +1 more source

Study of adverse drug reactions to antiretroviral therapy in a tertiary care hospital, Tirupati

open access: yesPerspectives in Clinical Research, 2020
Purpose: Human immunodeficiency virus-infected patients do not adhere to their antiretroviral therapy (ART) due to adverse effects of drugs. The continuous monitoring of adverse drug reactions (ADRs) may ensure the safe use of drugs in patients. Hence, a
Rajalakshmi Rukmangathen   +5 more
doaj   +1 more source

Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa. [PDF]

open access: yes, 2004
OBJECTIVE: To describe the approach used to promote adherence to antiretroviral therapy (ART) and to present the outcomes in the first primary care public sector ART project in South Africa.
Asselman, V   +5 more
core   +1 more source

Impact of Human Immunodeficiency Virus in the Pathogenesis and Outcome of Patients with Glioblastoma Multiforme. [PDF]

open access: yes, 2016
BackgroundImprovement in antiviral therapies have been accompanied by an increased frequency of non-Acquired Immune Deficiency Syndrome (AIDS) defining malignancies, such as glioblastoma multiforme.
Bui, Timothy T   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy